SWS Medical(SH:688410)2024-12-12 09:51Group 1: Market Expansion - The company has achieved overseas export revenue of 92.2253 million yuan, accounting for 22.06% of its main business income, with a year-on-year growth rate of 42.28% in the third quarter [2] - The company exports to nearly 90 countries and regions, indicating a steady increase in international market share [2] Group 2: Research and Development - In the first three quarters of 2024, the company invested 40.9611 million yuan in R&D, a 59.39% increase compared to the same period last year [2] - The company applied for 8 invention patents, 19 utility model patents, 5 design patents, and 5 copyrights in the first half of 2024, bringing the total to 52 invention patents (50 domestic, 2 foreign), 84 utility model patents, 32 design patents, and 44 software copyrights by mid-2024 [3] Group 3: Dividend Policy - In 2023, the company distributed cash dividends totaling 28.9461 million yuan (tax included) to shareholders, with a plan to issue 2.00 yuan (tax included) per 10 shares and a capital reserve increase of 4.9 shares per 10 shares [3] - The total cash dividends distributed in 2023 amounted to 72.0757 million yuan (tax included), with future dividend policies to be based on market conditions and company performance [3]